Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Yash Pharmaceuticals
483
•Yash Pharmaceuticals•December 6, 2024

Yash Pharmaceuticals – FDA 483, Dec 6, 2024

Record Details

During an inspection conducted by the FDA from December 2-6, 2024, Yash Pharmaceuticals in Roorkee, Uttarakhand, India, received a Form 483 detailing significant observations concerning their operational and quality control processes. The inspection highlighted two primary areas of concern. Firstly, the firm lacked appropriate controls over computer systems, specifically failing to safeguard test data from an FT-IR instrument, used for raw material identification, from potential deletion, indicating a data integrity vulnerability. Secondly, the responsibilities and procedures of the quality control unit were found to be inadequately documented. Deficiencies included an incomplete written procedure for data review, which lacked comprehensive verification steps for HPLC analysis. Furthermore, the procedures for system suitability tests were insufficient, failing to provide clear instructions for manual integration of chromatographic peaks, including requirements for scientific justification, management approval, and proper logging. Finally, the HPLC operating procedure was deemed inadequate for not outlining guidelines for handling trial or single injections, such as naming conventions, scientific rationale, and limits on their use. Yash Pharmaceuticals is expected to implement robust corrective and preventive actions to address these observations and ensure compliance with good manufacturing practices.

Company
Yash Pharmaceuticals
Inspection date
December 6, 2024
Product type
drugs
Office
Office of Inspections and Investigations
People
  • Truong X. Nguyen (Investigator)
  • Atri Y. Shah (Managing Director)
View Company Profile

ID · 0ee755f7-ba82-4198-adfa-a26bf638d995

Other documents for Yash Pharmaceuticals
  • 483 - 2019-09-03September 3, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Yash Pharmaceuticals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.